Stout served as the exclusive financial advisor to STATinMED Research in connection with its sale to Ancor Capital Partners, a Dallas-based private equity firm.

Founded in 2007, STATinMED Research is one of the world’s leading data and analytics companies focused on health economics and outcomes research (HEOR). STATinMED is transforming the way health care uses data to accelerate research and generate “real world evidence” that provides enhanced decision-making capabilities for the healthcare market. Using its customized research methodologies and a diverse set of data sources, STATinMED draws on millions of data points to develop strategies that deliver better clinical outcomes, higher cost savings, and greater value at every stage of the pharmaceutical product lifecycle. STATinMED collaborates with its clients in the pharmaceutical, biotechnology, and health information fields to deliver demonstrable results that lead to better overall quality of patient care.

View full news release